| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.41e-12 | 20 | 39 | 6 | GO:0061665 | |
| GeneOntologyMolecularFunction | small GTPase binding | RGPD1 RGPD4 RGPD2 RANBP2 NCF2 NOX1 ASB14 RGPD8 CHM DOCK9 RGPD3 | 1.75e-11 | 321 | 39 | 11 | GO:0031267 |
| GeneOntologyMolecularFunction | GTPase binding | RGPD1 RGPD4 RGPD2 RANBP2 NCF2 NOX1 ASB14 RGPD8 CHM DOCK9 RGPD3 | 6.00e-11 | 360 | 39 | 11 | GO:0051020 |
| GeneOntologyMolecularFunction | SUMO transferase activity | 6.92e-11 | 36 | 39 | 6 | GO:0019789 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 5.54e-10 | 50 | 39 | 6 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 7.97e-10 | 53 | 39 | 6 | GO:0016859 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 5.55e-08 | 279 | 39 | 8 | GO:0005096 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 4.39e-07 | 507 | 39 | 9 | GO:0030695 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 4.39e-07 | 507 | 39 | 9 | GO:0060589 | |
| GeneOntologyMolecularFunction | isomerase activity | 1.83e-06 | 192 | 39 | 6 | GO:0016853 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 3.70e-06 | 656 | 39 | 9 | GO:0008047 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.05e-05 | 398 | 39 | 7 | GO:0061659 | |
| GeneOntologyMolecularFunction | histone H3K9 trimethyltransferase activity | 3.70e-05 | 5 | 39 | 2 | GO:0140949 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 5.28e-05 | 512 | 39 | 7 | GO:0019787 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | RGPD1 RGPD4 RGPD2 NCOR1 RANBP2 NCF2 RGPD8 CHM DOCK9 RGPD3 RGPD5 | 5.84e-05 | 1418 | 39 | 11 | GO:0030234 |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 6.72e-05 | 532 | 39 | 7 | GO:0016755 | |
| GeneOntologyMolecularFunction | molecular function activator activity | 9.50e-05 | 1233 | 39 | 10 | GO:0140677 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 1.05e-04 | 775 | 39 | 8 | GO:0016746 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 1.66e-04 | 10 | 39 | 2 | GO:0140947 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 2.42e-04 | 12 | 39 | 2 | GO:0016175 | |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 2.86e-04 | 13 | 39 | 2 | GO:0046974 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 6.91e-04 | 20 | 39 | 2 | GO:0050664 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 9.16e-04 | 23 | 39 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 3.34e-03 | 44 | 39 | 2 | GO:0140938 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 5.17e-03 | 55 | 39 | 2 | GO:0042974 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 7.81e-03 | 68 | 39 | 2 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 8.03e-03 | 69 | 39 | 2 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 8.48e-03 | 71 | 39 | 2 | GO:0042054 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.00e-02 | 229 | 39 | 3 | GO:0140993 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.00e-02 | 229 | 39 | 3 | GO:0003714 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 2.55e-15 | 9 | 39 | 6 | GO:0033133 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 3.72e-15 | 20 | 39 | 7 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 6.38e-15 | 10 | 39 | 6 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 5.19e-14 | 13 | 39 | 6 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 9.07e-14 | 14 | 39 | 6 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 8.07e-11 | 38 | 39 | 6 | GO:0000413 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 7.38e-10 | 54 | 39 | 6 | GO:0018208 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 2.65e-09 | 195 | 39 | 8 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 3.36e-09 | 201 | 39 | 8 | GO:0051170 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 4.00e-09 | 71 | 39 | 6 | GO:0006111 | |
| GeneOntologyBiologicalProcess | RNA transport | 3.43e-08 | 175 | 39 | 7 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 3.43e-08 | 175 | 39 | 7 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 3.86e-08 | 178 | 39 | 7 | GO:0051236 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 5.98e-08 | 111 | 39 | 6 | GO:0006094 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 7.40e-08 | 115 | 39 | 6 | GO:0019319 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 1.00e-07 | 121 | 39 | 6 | GO:0046364 | |
| GeneOntologyBiologicalProcess | RNA localization | 1.50e-07 | 217 | 39 | 7 | GO:0006403 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 1.68e-07 | 132 | 39 | 6 | GO:0043255 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 1.84e-07 | 134 | 39 | 6 | GO:0010906 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 2.29e-07 | 231 | 39 | 7 | GO:0006109 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD1 RGPD4 RGPD2 TRAPPC11 RANBP2 SPG11 ASB14 REEP1 RGPD8 CHM LYST PICK1 RGPD3 RGPD5 | 2.82e-07 | 1496 | 39 | 14 | GO:0046907 |
| GeneOntologyBiologicalProcess | mRNA transport | 2.93e-07 | 145 | 39 | 6 | GO:0051028 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 3.19e-07 | 362 | 39 | 8 | GO:0034504 | |
| GeneOntologyBiologicalProcess | protein folding | 3.50e-07 | 246 | 39 | 7 | GO:0006457 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 3.80e-07 | 249 | 39 | 7 | GO:0015931 | |
| GeneOntologyBiologicalProcess | nuclear transport | 4.42e-07 | 378 | 39 | 8 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 4.42e-07 | 378 | 39 | 8 | GO:0006913 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | 8.23e-07 | 740 | 39 | 10 | GO:0006886 | |
| GeneOntologyBiologicalProcess | nuclear export | 1.22e-06 | 185 | 39 | 6 | GO:0051168 | |
| GeneOntologyBiologicalProcess | regulation of small molecule metabolic process | 1.25e-06 | 434 | 39 | 8 | GO:0062012 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | 4.45e-06 | 515 | 39 | 8 | GO:0072594 | |
| GeneOntologyBiologicalProcess | glucose metabolic process | 6.06e-06 | 244 | 39 | 6 | GO:0006006 | |
| GeneOntologyBiologicalProcess | carbohydrate biosynthetic process | 6.50e-06 | 247 | 39 | 6 | GO:0016051 | |
| GeneOntologyBiologicalProcess | hexose metabolic process | 1.44e-05 | 284 | 39 | 6 | GO:0019318 | |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | 2.36e-05 | 310 | 39 | 6 | GO:0005996 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 1.04e-04 | 405 | 39 | 6 | GO:0033674 | |
| GeneOntologyBiologicalProcess | protein maturation | 1.41e-04 | 619 | 39 | 7 | GO:0051604 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | 1.84e-04 | 646 | 39 | 7 | GO:0005975 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | 2.92e-04 | 490 | 39 | 6 | GO:0051347 | |
| GeneOntologyBiologicalProcess | epigenetic programming in the zygotic pronuclei | 4.65e-04 | 17 | 39 | 2 | GO:0044725 | |
| GeneOntologyBiologicalProcess | negative regulation of androgen receptor signaling pathway | 4.65e-04 | 17 | 39 | 2 | GO:0060766 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen levels | 4.92e-04 | 195 | 39 | 4 | GO:0071453 | |
| GeneOntologyBiologicalProcess | regulation of microtubule nucleation | 5.84e-04 | 19 | 39 | 2 | GO:0010968 | |
| GeneOntologyBiologicalProcess | regulation of multicellular organism growth | 7.21e-04 | 93 | 39 | 3 | GO:0040014 | |
| GeneOntologyBiologicalProcess | endocytosis | 8.13e-04 | 827 | 39 | 7 | GO:0006897 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | 8.47e-04 | 1091 | 39 | 8 | GO:0033365 | |
| GeneOntologyBiologicalProcess | dendritic spine maintenance | 1.47e-03 | 30 | 39 | 2 | GO:0097062 | |
| GeneOntologyBiologicalProcess | regulation of androgen receptor signaling pathway | 1.56e-03 | 31 | 39 | 2 | GO:0060765 | |
| GeneOntologyBiologicalProcess | negative regulation of miRNA transcription | 1.56e-03 | 31 | 39 | 2 | GO:1902894 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | 1.57e-03 | 676 | 39 | 6 | GO:0044283 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | 1.69e-03 | 686 | 39 | 6 | GO:0043549 | |
| GeneOntologyBiologicalProcess | phagocytosis | 1.74e-03 | 274 | 39 | 4 | GO:0006909 | |
| GeneOntologyBiologicalProcess | negative regulation of miRNA metabolic process | 1.88e-03 | 34 | 39 | 2 | GO:2000629 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 7.87e-16 | 8 | 39 | 6 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 5.88e-15 | 10 | 39 | 6 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 8.37e-14 | 14 | 39 | 6 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 5.15e-13 | 18 | 39 | 6 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.07e-12 | 20 | 39 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.50e-12 | 21 | 39 | 6 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear pore | 6.74e-10 | 101 | 39 | 7 | GO:0005643 | |
| GeneOntologyCellularComponent | inclusion body | 1.57e-08 | 90 | 39 | 6 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD1 RGPD4 RGPD2 NCOR1 NCOR2 RANBP2 RGPD8 KAT8 SUV39H1 RGPD3 RGPD5 | 2.93e-05 | 1377 | 39 | 11 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear membrane | 4.25e-05 | 349 | 39 | 6 | GO:0031965 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 4.31e-05 | 934 | 39 | 9 | GO:0048471 | |
| GeneOntologyCellularComponent | nuclear envelope | 6.97e-05 | 560 | 39 | 7 | GO:0005635 | |
| GeneOntologyCellularComponent | transferase complex | 3.39e-04 | 963 | 39 | 8 | GO:1990234 | |
| GeneOntologyCellularComponent | NADPH oxidase complex | 5.09e-04 | 18 | 39 | 2 | GO:0043020 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 1.70e-03 | 276 | 39 | 4 | GO:0000775 | |
| GeneOntologyCellularComponent | nuclear periphery | 3.96e-03 | 171 | 39 | 3 | GO:0034399 | |
| GeneOntologyCellularComponent | organelle envelope | 4.39e-03 | 1435 | 39 | 8 | GO:0031967 | |
| HumanPheno | Thenar muscle atrophy | 3.36e-06 | 15 | 11 | 3 | HP:0003393 | |
| HumanPheno | Abnormal calf musculature morphology | 1.06e-05 | 71 | 11 | 4 | HP:0001430 | |
| HumanPheno | Motor polyneuropathy | 6.07e-05 | 38 | 11 | 3 | HP:0007178 | |
| HumanPheno | Bulbar signs | 9.46e-05 | 44 | 11 | 3 | HP:0002483 | |
| HumanPheno | Abnormality of the musculature of the hand | 9.98e-05 | 125 | 11 | 4 | HP:0001421 | |
| HumanPheno | Foot dorsiflexor weakness | 1.73e-04 | 144 | 11 | 4 | HP:0009027 | |
| HumanPheno | Hand muscle atrophy | 1.75e-04 | 54 | 11 | 3 | HP:0009130 | |
| HumanPheno | Abnormality of the foot musculature | 2.08e-04 | 151 | 11 | 4 | HP:0001436 | |
| HumanPheno | Abnormality of the musculature of the lower limbs | 2.25e-04 | 297 | 11 | 5 | HP:0001437 | |
| HumanPheno | Impaired neutrophil bactericidal activity | 2.31e-04 | 11 | 11 | 2 | HP:0011993 | |
| HumanPheno | Ankle contracture | 2.40e-04 | 60 | 11 | 3 | HP:0034677 | |
| HumanPheno | Distal upper limb amyotrophy | 3.48e-04 | 68 | 11 | 3 | HP:0007149 | |
| HumanPheno | Proximal muscle weakness | 4.25e-04 | 340 | 11 | 5 | HP:0003701 | |
| HumanPheno | Proximal muscle weakness in lower limbs | 4.64e-04 | 186 | 11 | 4 | HP:0008994 | |
| HumanPheno | Abnormality of neutrophil physiology | 5.67e-04 | 17 | 11 | 2 | HP:0011990 | |
| HumanPheno | Upper limb amyotrophy | 6.26e-04 | 83 | 11 | 3 | HP:0009129 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 6.90e-13 | 16 | 32 | 6 | MP:0003701 | |
| MousePheno | abnormal morula morphology | 1.95e-11 | 26 | 32 | 6 | MP:0012058 | |
| MousePheno | decreased tumor latency | 5.00e-11 | 30 | 32 | 6 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 6.19e-11 | 31 | 32 | 6 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 1.13e-10 | 34 | 32 | 6 | MP:0010307 | |
| MousePheno | abnormal blastocyst formation | 2.71e-10 | 39 | 32 | 6 | MP:0012128 | |
| MousePheno | aneuploidy | 4.45e-09 | 61 | 32 | 6 | MP:0004024 | |
| MousePheno | abnormal rod electrophysiology | 7.65e-09 | 119 | 32 | 7 | MP:0004021 | |
| MousePheno | increased hepatocellular carcinoma incidence | 1.04e-08 | 70 | 32 | 6 | MP:0003331 | |
| MousePheno | abnormal chromosome morphology | 1.14e-08 | 126 | 32 | 7 | MP:0003702 | |
| MousePheno | abnormal mitosis | 1.27e-08 | 128 | 32 | 7 | MP:0004046 | |
| MousePheno | increased lung carcinoma incidence | 2.00e-08 | 78 | 32 | 6 | MP:0008714 | |
| MousePheno | abnormal chromosome number | 3.62e-08 | 86 | 32 | 6 | MP:0004023 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 5.97e-08 | 160 | 32 | 7 | MP:0005659 | |
| MousePheno | enlarged epididymis | 8.45e-08 | 99 | 32 | 6 | MP:0004931 | |
| MousePheno | increased sarcoma incidence | 1.01e-07 | 102 | 32 | 6 | MP:0002032 | |
| MousePheno | increased incidence of induced tumors | 1.02e-07 | 173 | 32 | 7 | MP:0002021 | |
| MousePheno | increased lung tumor incidence | 1.35e-07 | 107 | 32 | 6 | MP:0008014 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 1.35e-07 | 107 | 32 | 6 | MP:0003694 | |
| MousePheno | increased respiratory system tumor incidence | 1.35e-07 | 107 | 32 | 6 | MP:0010298 | |
| MousePheno | abnormal cell nucleus morphology | 1.56e-07 | 184 | 32 | 7 | MP:0003111 | |
| MousePheno | decreased susceptibility to weight gain | 1.68e-07 | 186 | 32 | 7 | MP:0010182 | |
| MousePheno | increased liver tumor incidence | 1.68e-07 | 111 | 32 | 6 | MP:0008019 | |
| MousePheno | increased hepatobiliary system tumor incidence | 1.68e-07 | 111 | 32 | 6 | MP:0010297 | |
| MousePheno | abnormal blastocyst hatching | 1.86e-07 | 113 | 32 | 6 | MP:0003693 | |
| MousePheno | abnormal intracellular organelle morphology | 2.26e-07 | 546 | 32 | 10 | MP:0014239 | |
| MousePheno | increased energy expenditure | 2.39e-07 | 196 | 32 | 7 | MP:0004889 | |
| MousePheno | abnormal susceptibility to weight gain | 3.45e-07 | 309 | 32 | 8 | MP:0011117 | |
| MousePheno | abnormal energy expenditure | 3.81e-07 | 313 | 32 | 8 | MP:0005450 | |
| MousePheno | abnormal energy homeostasis | 4.72e-07 | 322 | 32 | 8 | MP:0005448 | |
| MousePheno | abnormal eye electrophysiology | 6.66e-07 | 228 | 32 | 7 | MP:0005551 | |
| MousePheno | increased incidence of tumors by chemical induction | 6.91e-07 | 141 | 32 | 6 | MP:0004499 | |
| MousePheno | increased classified tumor incidence | 1.68e-06 | 381 | 32 | 8 | MP:0010273 | |
| MousePheno | abnormal classified tumor incidence | 1.78e-06 | 384 | 32 | 8 | MP:0020188 | |
| MousePheno | abnormal epididymis size | 1.80e-06 | 166 | 32 | 6 | MP:0004926 | |
| MousePheno | increased tumor incidence | 1.94e-06 | 530 | 32 | 9 | MP:0002020 | |
| MousePheno | abnormal incidence of induced tumors | 2.02e-06 | 269 | 32 | 7 | MP:0013151 | |
| MousePheno | abnormal preimplantation embryo development | 2.14e-06 | 171 | 32 | 6 | MP:0009781 | |
| MousePheno | increased organ/body region tumor incidence | 2.20e-06 | 395 | 32 | 8 | MP:0010274 | |
| MousePheno | abnormal organ/body region tumor incidence | 2.46e-06 | 401 | 32 | 8 | MP:0013152 | |
| MousePheno | abnormal preimplantation embryo morphology | 2.82e-06 | 283 | 32 | 7 | MP:0014137 | |
| MousePheno | increased carcinoma incidence | 4.85e-06 | 197 | 32 | 6 | MP:0002038 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 5.76e-06 | 203 | 32 | 6 | MP:0011094 | |
| MousePheno | abnormal tumor incidence | 8.52e-06 | 635 | 32 | 9 | MP:0002019 | |
| MousePheno | abnormal tumor susceptibility | 1.03e-05 | 650 | 32 | 9 | MP:0002166 | |
| MousePheno | increased malignant tumor incidence | 1.40e-05 | 237 | 32 | 6 | MP:0002018 | |
| MousePheno | embryonic lethality before implantation | 1.57e-05 | 242 | 32 | 6 | MP:0006204 | |
| MousePheno | abnormal epididymis morphology | 2.86e-05 | 269 | 32 | 6 | MP:0002631 | |
| MousePheno | neoplasm | 3.12e-05 | 747 | 32 | 9 | MP:0002006 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 4.03e-05 | 286 | 32 | 6 | MP:0008873 | |
| MousePheno | abnormal eye physiology | 4.97e-05 | 606 | 32 | 8 | MP:0005253 | |
| MousePheno | abnormal cell cycle | 1.42e-04 | 520 | 32 | 7 | MP:0003077 | |
| MousePheno | embryonic lethality prior to organogenesis | RGPD1 CKAP5 RGPD4 MRC1 RGPD2 TRAPPC11 RANBP2 RGPD8 KAT8 RGPD3 | 2.39e-04 | 1204 | 32 | 10 | MP:0013292 |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | 2.68e-04 | 772 | 32 | 8 | MP:0014259 | |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | 2.85e-04 | 779 | 32 | 8 | MP:0014257 | |
| MousePheno | abnormal physiological response to xenobiotic | 6.17e-04 | 662 | 32 | 7 | MP:0008872 | |
| MousePheno | impaired glucose tolerance | 6.73e-04 | 480 | 32 | 6 | MP:0005293 | |
| MousePheno | abnormal embryo development | 6.79e-04 | 1370 | 32 | 10 | MP:0001672 | |
| MousePheno | embryonic lethality prior to tooth bud stage | RGPD1 CKAP5 RGPD4 MRC1 RGPD2 TRAPPC11 RANBP2 RGPD8 KAT8 RGPD3 | 7.32e-04 | 1383 | 32 | 10 | MP:0013293 |
| MousePheno | abnormal liver morphology | RGPD1 RGPD4 RGPD2 NCOR1 NCOR2 RANBP2 RGPD8 DNAJC7 KAT8 RGPD3 | 9.67e-04 | 1433 | 32 | 10 | MP:0000598 |
| MousePheno | abnormal hepatobiliary system morphology | RGPD1 RGPD4 RGPD2 NCOR1 NCOR2 RANBP2 RGPD8 DNAJC7 KAT8 RGPD3 | 1.22e-03 | 1476 | 32 | 10 | MP:0002138 |
| MousePheno | abnormal lung morphology | 1.47e-03 | 767 | 32 | 7 | MP:0001175 | |
| MousePheno | small testis | 2.20e-03 | 823 | 32 | 7 | MP:0001147 | |
| MousePheno | abnormal susceptibility to fungal infection | 2.26e-03 | 31 | 32 | 2 | MP:0020183 | |
| MousePheno | abnormal white fat cell morphology | 3.00e-03 | 127 | 32 | 3 | MP:0009117 | |
| Domain | Ran_BP1 | 7.70e-17 | 12 | 39 | 7 | PF00638 | |
| Domain | RANBD1 | 7.70e-17 | 12 | 39 | 7 | PS50196 | |
| Domain | RanBD | 1.66e-16 | 13 | 39 | 7 | SM00160 | |
| Domain | Ran_bind_dom | 1.66e-16 | 13 | 39 | 7 | IPR000156 | |
| Domain | TPR-contain_dom | RGPD1 RGPD4 TTC27 RGPD2 RANBP2 NCF2 RGPD8 DNAJC7 EDRF1 RGPD3 RGPD5 | 8.55e-15 | 150 | 39 | 11 | IPR013026 |
| Domain | TPR | RGPD1 RGPD4 TTC27 RGPD2 RANBP2 NCF2 RGPD8 DNAJC7 EDRF1 RGPD3 RGPD5 | 2.47e-14 | 165 | 39 | 11 | PS50005 |
| Domain | TPR_REGION | RGPD1 RGPD4 TTC27 RGPD2 RANBP2 NCF2 RGPD8 DNAJC7 EDRF1 RGPD3 RGPD5 | 2.47e-14 | 165 | 39 | 11 | PS50293 |
| Domain | GRIP | 2.54e-14 | 11 | 39 | 6 | PF01465 | |
| Domain | Grip | 2.54e-14 | 11 | 39 | 6 | SM00755 | |
| Domain | GRIP_dom | 5.07e-14 | 12 | 39 | 6 | IPR000237 | |
| Domain | GRIP | 5.07e-14 | 12 | 39 | 6 | PS50913 | |
| Domain | GCC2_Rab_bind | 6.37e-13 | 7 | 39 | 5 | IPR032023 | |
| Domain | Rab_bind | 6.37e-13 | 7 | 39 | 5 | PF16704 | |
| Domain | TPR-like_helical_dom | RGPD1 RGPD4 TTC27 RGPD2 RANBP2 NCF2 RGPD8 DNAJC7 EDRF1 RGPD3 RGPD5 | 1.11e-12 | 233 | 39 | 11 | IPR011990 |
| Domain | TPR | 4.80e-12 | 129 | 39 | 9 | SM00028 | |
| Domain | TPR_repeat | 6.33e-12 | 133 | 39 | 9 | IPR019734 | |
| Domain | - | 7.61e-12 | 10 | 39 | 5 | 1.10.220.60 | |
| Domain | - | RGPD1 RGPD4 TTC27 RGPD2 RANBP2 NCF2 RGPD8 DNAJC7 EDRF1 RGPD3 | 1.08e-11 | 207 | 39 | 10 | 1.25.40.10 |
| Domain | TPR_1 | 3.04e-08 | 90 | 39 | 6 | PF00515 | |
| Domain | TPR_1 | 3.04e-08 | 90 | 39 | 6 | IPR001440 | |
| Domain | PH_dom-like | 1.77e-07 | 426 | 39 | 9 | IPR011993 | |
| Domain | SAM_MT43_SUVAR39_3 | 4.25e-06 | 2 | 39 | 2 | PS51579 | |
| Domain | Histone_H3-K9_MeTrfase | 4.25e-06 | 2 | 39 | 2 | IPR011381 | |
| Domain | GPS2_interact | 4.25e-06 | 2 | 39 | 2 | PF15784 | |
| Domain | N-CoR_GPS2_interact | 4.25e-06 | 2 | 39 | 2 | IPR031557 | |
| Domain | - | 1.44e-05 | 391 | 39 | 7 | 2.30.29.30 | |
| Domain | CHROMO_2 | 2.66e-05 | 28 | 39 | 3 | PS50013 | |
| Domain | CHROMO_1 | 2.66e-05 | 28 | 39 | 3 | PS00598 | |
| Domain | Chromodomain-like | 4.00e-05 | 32 | 39 | 3 | IPR016197 | |
| Domain | CHROMO | 4.40e-05 | 33 | 39 | 3 | SM00298 | |
| Domain | Chromo/shadow_dom | 4.40e-05 | 33 | 39 | 3 | IPR000953 | |
| Domain | PreSET | 8.86e-05 | 7 | 39 | 2 | SM00468 | |
| Domain | Pre-SET | 8.86e-05 | 7 | 39 | 2 | PF05033 | |
| Domain | Pre-SET_dom | 8.86e-05 | 7 | 39 | 2 | IPR007728 | |
| Domain | PRE_SET | 8.86e-05 | 7 | 39 | 2 | PS50867 | |
| Domain | Post-SET_dom | 5.01e-04 | 16 | 39 | 2 | IPR003616 | |
| Domain | PostSET | 5.01e-04 | 16 | 39 | 2 | SM00508 | |
| Domain | POST_SET | 5.01e-04 | 16 | 39 | 2 | PS50868 | |
| Domain | Chromodomain_CS | 6.36e-04 | 18 | 39 | 2 | IPR023779 | |
| Domain | Chromo_domain | 1.14e-03 | 24 | 39 | 2 | IPR023780 | |
| Domain | Chromo | 1.34e-03 | 26 | 39 | 2 | PF00385 | |
| Domain | SANT_dom | 1.34e-03 | 26 | 39 | 2 | IPR017884 | |
| Domain | SANT | 1.55e-03 | 28 | 39 | 2 | PS51293 | |
| Domain | Myb_DNA-binding | 2.42e-03 | 35 | 39 | 2 | PF00249 | |
| Domain | MYB_LIKE | 2.85e-03 | 38 | 39 | 2 | PS50090 | |
| Domain | SET | 3.31e-03 | 41 | 39 | 2 | PF00856 | |
| Domain | SET | 4.15e-03 | 46 | 39 | 2 | SM00317 | |
| Domain | SET_dom | 4.89e-03 | 50 | 39 | 2 | IPR001214 | |
| Domain | SANT | 4.89e-03 | 50 | 39 | 2 | SM00717 | |
| Domain | SET | 4.89e-03 | 50 | 39 | 2 | PS50280 | |
| Domain | SANT/Myb | 5.27e-03 | 52 | 39 | 2 | IPR001005 | |
| Domain | TPR_8 | 5.47e-03 | 53 | 39 | 2 | PF13181 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.52e-12 | 18 | 32 | 6 | MM1549 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 3.03e-10 | 40 | 32 | 6 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 3.54e-10 | 41 | 32 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 4.12e-10 | 42 | 32 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 4.79e-10 | 43 | 32 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 8.37e-10 | 47 | 32 | 6 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.09e-09 | 49 | 32 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.23e-09 | 50 | 32 | 6 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.40e-09 | 51 | 32 | 6 | MM15151 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 2.13e-09 | 100 | 32 | 7 | MM14561 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.23e-09 | 55 | 32 | 6 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 3.10e-09 | 58 | 32 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 3.10e-09 | 58 | 32 | 6 | MM14736 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 3.76e-09 | 257 | 32 | 9 | MM14755 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 6.26e-09 | 65 | 32 | 6 | MM15147 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 6.42e-09 | 117 | 32 | 7 | MM15387 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.21e-08 | 202 | 32 | 8 | MM15362 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.27e-08 | 129 | 32 | 7 | MM14894 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.27e-08 | 73 | 32 | 6 | MM14948 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 2.36e-08 | 141 | 32 | 7 | MM15266 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 2.58e-08 | 82 | 32 | 6 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 2.99e-08 | 84 | 32 | 6 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 3.45e-08 | 86 | 32 | 6 | MM15413 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 5.18e-08 | 92 | 32 | 6 | MM14951 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.87e-07 | 114 | 32 | 6 | MM15361 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 2.04e-07 | 193 | 32 | 7 | MM14890 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 7.50e-07 | 234 | 32 | 7 | MM14898 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 1.03e-06 | 649 | 32 | 10 | MM15690 | |
| Pathway | REACTOME_M_PHASE | 1.77e-06 | 387 | 32 | 8 | MM15364 | |
| Pathway | REACTOME_SUMOYLATION | 1.90e-06 | 169 | 32 | 6 | MM14919 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 2.00e-06 | 271 | 32 | 7 | MM15388 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | RGPD1 RGPD4 RGPD2 NCOR2 RANBP2 KCTD1 RGPD8 CHM KAT8 RGPD3 ZFP1 | 8.60e-06 | 1022 | 32 | 11 | MM15436 |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 1.26e-05 | 505 | 32 | 8 | MM15548 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.84e-05 | 271 | 32 | 6 | MM15406 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 3.21e-05 | 277 | 32 | 6 | MM15414 | |
| Pathway | REACTOME_CELL_CYCLE | 4.52e-05 | 603 | 32 | 8 | MM14635 | |
| Pathway | REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX | 1.04e-04 | 7 | 32 | 2 | M27899 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 1.78e-04 | 9 | 32 | 2 | M29809 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 3.39e-04 | 272 | 32 | 5 | M29619 | |
| Pathway | REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME | 3.83e-04 | 13 | 32 | 2 | M29766 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 4.41e-04 | 66 | 32 | 3 | M101 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 6.29e-04 | 175 | 32 | 4 | MM14941 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 1.34e-03 | 24 | 32 | 2 | M27553 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 1.45e-03 | 25 | 32 | 2 | MM15269 | |
| Pathway | REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS | 1.69e-03 | 27 | 32 | 2 | M29816 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.82e-03 | 28 | 32 | 2 | M6177 | |
| Pathway | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | 2.23e-03 | 31 | 32 | 2 | M669 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 2.25e-03 | 612 | 32 | 6 | MM15547 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 2.37e-03 | 32 | 32 | 2 | M27900 | |
| Pathway | PID_HDAC_CLASSII_PATHWAY | 2.68e-03 | 34 | 32 | 2 | M30 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 3.16e-03 | 37 | 32 | 2 | M29790 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 3.70e-03 | 138 | 32 | 3 | M29805 | |
| Pathway | KEGG_LYSINE_DEGRADATION | 4.45e-03 | 44 | 32 | 2 | M13720 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 4.85e-03 | 46 | 32 | 2 | MM14933 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 5.06e-03 | 47 | 32 | 2 | M29777 | |
| Pathway | PID_HES_HEY_PATHWAY | 5.28e-03 | 48 | 32 | 2 | M288 | |
| Pathway | WP_RETT_SYNDROME | 5.28e-03 | 48 | 32 | 2 | M39759 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 5.28e-03 | 48 | 32 | 2 | M611 | |
| Pathway | REACTOME_HCMV_INFECTION | 5.79e-03 | 162 | 32 | 3 | M29804 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 5.86e-03 | 323 | 32 | 4 | M27080 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 5.94e-03 | 51 | 32 | 2 | M665 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 6.17e-03 | 52 | 32 | 2 | M2404 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 6.40e-03 | 53 | 32 | 2 | M8276 | |
| Pathway | PID_RAC1_PATHWAY | 6.64e-03 | 54 | 32 | 2 | M278 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 7.16e-03 | 175 | 32 | 3 | MM15599 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | 7.23e-03 | 343 | 32 | 4 | MM15712 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 7.62e-03 | 58 | 32 | 2 | M29616 | |
| Pathway | PID_NOTCH_PATHWAY | 7.88e-03 | 59 | 32 | 2 | M17 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 8.14e-03 | 60 | 32 | 2 | M41830 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 8.22e-03 | 184 | 32 | 3 | M41809 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 8.40e-03 | 61 | 32 | 2 | M39540 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 8.94e-03 | 63 | 32 | 2 | M27862 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 9.22e-03 | 64 | 32 | 2 | M200 | |
| Pathway | REACTOME_INFECTIOUS_DISEASE | 9.41e-03 | 1081 | 32 | 7 | M27548 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 9.50e-03 | 65 | 32 | 2 | M39374 | |
| Pubmed | 9.29e-18 | 7 | 39 | 6 | 30944974 | ||
| Pubmed | 9.29e-18 | 7 | 39 | 6 | 38838144 | ||
| Pubmed | 9.29e-18 | 7 | 39 | 6 | 21205196 | ||
| Pubmed | 9.29e-18 | 7 | 39 | 6 | 18949001 | ||
| Pubmed | 9.29e-18 | 7 | 39 | 6 | 25187515 | ||
| Pubmed | 9.29e-18 | 7 | 39 | 6 | 9037092 | ||
| Pubmed | 9.29e-18 | 7 | 39 | 6 | 23536549 | ||
| Pubmed | 9.29e-18 | 7 | 39 | 6 | 8603673 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 9.29e-18 | 7 | 39 | 6 | 7559465 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 9.29e-18 | 7 | 39 | 6 | 15710750 | |
| Pubmed | 9.29e-18 | 7 | 39 | 6 | 26632511 | ||
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 9.29e-18 | 7 | 39 | 6 | 17372272 | |
| Pubmed | 9.29e-18 | 7 | 39 | 6 | 24403063 | ||
| Pubmed | 9.29e-18 | 7 | 39 | 6 | 23818861 | ||
| Pubmed | 9.29e-18 | 7 | 39 | 6 | 38657106 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 9.29e-18 | 7 | 39 | 6 | 11353387 | |
| Pubmed | 9.29e-18 | 7 | 39 | 6 | 12191015 | ||
| Pubmed | 9.29e-18 | 7 | 39 | 6 | 22821000 | ||
| Pubmed | 9.29e-18 | 7 | 39 | 6 | 20682751 | ||
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 3.71e-17 | 8 | 39 | 6 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 3.71e-17 | 8 | 39 | 6 | 21670213 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 3.71e-17 | 8 | 39 | 6 | 28745977 | |
| Pubmed | 3.71e-17 | 8 | 39 | 6 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 3.71e-17 | 8 | 39 | 6 | 21310149 | |
| Pubmed | 1.11e-16 | 9 | 39 | 6 | 9733766 | ||
| Pubmed | 1.11e-16 | 9 | 39 | 6 | 28100513 | ||
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.11e-16 | 9 | 39 | 6 | 18394993 | |
| Pubmed | 1.11e-16 | 9 | 39 | 6 | 28877029 | ||
| Pubmed | 1.11e-16 | 9 | 39 | 6 | 11553612 | ||
| Pubmed | 1.11e-16 | 9 | 39 | 6 | 17887960 | ||
| Pubmed | 1.11e-16 | 9 | 39 | 6 | 10601307 | ||
| Pubmed | 2.78e-16 | 10 | 39 | 6 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 2.78e-16 | 10 | 39 | 6 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 2.78e-16 | 10 | 39 | 6 | 8857542 | |
| Pubmed | 2.78e-16 | 10 | 39 | 6 | 21859863 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 6.11e-16 | 11 | 39 | 6 | 35771867 | |
| Pubmed | 6.11e-16 | 11 | 39 | 6 | 17069463 | ||
| Pubmed | 6.11e-16 | 11 | 39 | 6 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 2.27e-15 | 13 | 39 | 6 | 31427429 | |
| Pubmed | 6.60e-15 | 15 | 39 | 6 | 14697343 | ||
| Pubmed | 9.78e-14 | 22 | 39 | 6 | 27717094 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 3.57e-12 | 38 | 39 | 6 | 12791264 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 4.38e-12 | 146 | 39 | 8 | 23892456 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD1 CKAP5 TMEM63B RGPD4 TTC27 RGPD2 RANBP2 HAUS3 RGPD8 AZGP1 KAT8 RGPD3 RGPD5 ZFP1 | 1.28e-11 | 1155 | 39 | 14 | 20360068 |
| Pubmed | RGPD1 CKAP5 RGPD4 TTC27 RGPD2 NCOR1 NCOR2 RANBP2 RGPD8 RGPD3 | 2.63e-11 | 418 | 39 | 10 | 34709266 | |
| Pubmed | 9.77e-11 | 215 | 39 | 8 | 35973513 | ||
| Pubmed | 5.85e-10 | 86 | 39 | 6 | 37253089 | ||
| Pubmed | 1.38e-09 | 99 | 39 | 6 | 27746211 | ||
| Pubmed | RGPD1 RGPD4 RGPD2 RNF213 RANBP2 NEB RGPD8 DNAJC7 AZGP1 RGPD3 RGPD5 | 1.45e-09 | 844 | 39 | 11 | 25963833 | |
| Pubmed | RGPD1 RGPD4 RGPD2 NCOR1 RANBP2 SPG11 NEB RGPD8 DNAJC7 LYST PICK1 RGPD3 RGPD5 | 3.01e-09 | 1442 | 39 | 13 | 35575683 | |
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 9480752 | ||
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 8.98e-09 | 135 | 39 | 6 | 31077711 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.90e-08 | 153 | 39 | 6 | 26365490 | |
| Pubmed | RGPD1 CKAP5 RGPD4 RGPD2 RANBP2 REEP1 RGPD8 SUGP2 DOCK9 FAM177A1 RGPD3 | 3.20e-08 | 1139 | 39 | 11 | 36417873 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 1.67e-07 | 370 | 39 | 7 | 22922362 | |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 1.92e-07 | 226 | 39 | 6 | 37839992 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 2.19e-07 | 231 | 39 | 6 | 16452087 | |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | 5.53e-07 | 442 | 39 | 7 | 15815621 | |
| Pubmed | 5.88e-07 | 15 | 39 | 3 | 35907431 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 6.25e-07 | 665 | 39 | 8 | 30457570 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD1 RGPD4 TTC27 RGPD2 NCOR1 RANBP2 RGPD8 DNAJC7 RGPD3 RGPD5 | 8.96e-07 | 1257 | 39 | 10 | 37317656 |
| Pubmed | 9.26e-07 | 963 | 39 | 9 | 28671696 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 14690610 | ||
| Pubmed | Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. | 1.23e-06 | 2 | 39 | 2 | 14690609 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 21131350 | ||
| Pubmed | Regulation of corepressor alternative mRNA splicing by hormonal and metabolic signaling. | 1.23e-06 | 2 | 39 | 2 | 26166430 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 19299558 | ||
| Pubmed | Unique forms of human and mouse nuclear receptor corepressor SMRT. | 1.23e-06 | 2 | 39 | 2 | 10077563 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 29531310 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 14702045 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 11701123 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 38719473 | ||
| Pubmed | CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas. | 1.23e-06 | 2 | 39 | 2 | 27733359 | |
| Pubmed | Extreme disruption of heterochromatin is required for accelerated hematopoietic aging. | 1.23e-06 | 2 | 39 | 2 | 32305044 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 39106294 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 23451023 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 24981170 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 22944139 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 28833505 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 28760199 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 14765126 | ||
| Pubmed | Evolution of NCoR-1 and NCoR-2 corepressor alternative mRNA splicing in placental mammals. | 1.23e-06 | 2 | 39 | 2 | 31208445 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 27426629 | ||
| Pubmed | Functional interactions with Pit-1 reorganize co-repressor complexes in the living cell nucleus. | 3.67e-06 | 3 | 39 | 2 | 16030140 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 34390859 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 21896933 | ||
| Pubmed | Oligomerization of ETO is obligatory for corepressor interaction. | 3.67e-06 | 3 | 39 | 2 | 11113190 | |
| Pubmed | Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor. | 3.67e-06 | 3 | 39 | 2 | 19098224 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 16373395 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 31404087 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 12011091 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 21518914 | ||
| Pubmed | The histone H3K9 methyltransferase SUV39H links SIRT1 repression to myocardial infarction. | 3.67e-06 | 3 | 39 | 2 | 28361889 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 22337871 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 15802375 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 15788566 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 36238311 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 10406466 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 36316474 | ||
| Pubmed | Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3Â in vivo. | 3.67e-06 | 3 | 39 | 2 | 23292142 | |
| Interaction | RGPD4 interactions | 9.60e-15 | 22 | 39 | 7 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 4.96e-14 | 27 | 39 | 7 | int:RGPD2 | |
| Interaction | RGPD3 interactions | 3.42e-12 | 47 | 39 | 7 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 4.66e-12 | 49 | 39 | 7 | int:RGPD1 | |
| Interaction | RGPD8 interactions | 9.42e-11 | 74 | 39 | 7 | int:RGPD8 | |
| Interaction | RGPD5 interactions | 6.05e-10 | 96 | 39 | 7 | int:RGPD5 | |
| Interaction | NPIPB6 interactions | 3.59e-08 | 18 | 39 | 4 | int:NPIPB6 | |
| Interaction | NPAS1 interactions | 3.98e-07 | 245 | 39 | 7 | int:NPAS1 | |
| Interaction | MCM2 interactions | RGPD1 RGPD4 RGPD2 RNF213 RANBP2 NEB RGPD8 P2RX4 DNAJC7 AZGP1 RGPD3 RGPD5 | 5.42e-07 | 1081 | 39 | 12 | int:MCM2 |
| Interaction | RICTOR interactions | 1.28e-06 | 759 | 39 | 10 | int:RICTOR | |
| Interaction | RAN interactions | 2.91e-06 | 475 | 39 | 8 | int:RAN | |
| Interaction | RANBP2 interactions | 5.24e-06 | 361 | 39 | 7 | int:RANBP2 | |
| Interaction | ESRP1 interactions | 1.46e-05 | 77 | 39 | 4 | int:ESRP1 | |
| Interaction | INSYN1 interactions | 1.79e-05 | 169 | 39 | 5 | int:INSYN1 | |
| Interaction | NEMP1 interactions | 2.60e-05 | 89 | 39 | 4 | int:NEMP1 | |
| Interaction | FOXL1 interactions | 3.64e-05 | 196 | 39 | 5 | int:FOXL1 | |
| Interaction | RCC1 interactions | 4.10e-05 | 201 | 39 | 5 | int:RCC1 | |
| Interaction | ODAD3 interactions | 7.30e-05 | 42 | 39 | 3 | int:ODAD3 | |
| Interaction | NR1I2 interactions | 1.09e-04 | 48 | 39 | 3 | int:NR1I2 | |
| Interaction | ZNF276 interactions | 1.16e-04 | 49 | 39 | 3 | int:ZNF276 | |
| Interaction | C9orf72 interactions | RGPD1 RGPD4 TTC27 RGPD2 NCOR1 RANBP2 RGPD8 DNAJC7 RGPD3 RGPD5 | 1.54e-04 | 1319 | 39 | 10 | int:C9orf72 |
| Interaction | YWHAZ interactions | 1.54e-04 | 1319 | 39 | 10 | int:YWHAZ | |
| Interaction | D2HGDH interactions | 1.79e-04 | 146 | 39 | 4 | int:D2HGDH | |
| Interaction | ATXN1L interactions | 1.98e-04 | 150 | 39 | 4 | int:ATXN1L | |
| Interaction | NXF2 interactions | 2.69e-04 | 65 | 39 | 3 | int:NXF2 | |
| Interaction | C8orf74 interactions | 2.81e-04 | 13 | 39 | 2 | int:C8orf74 | |
| Interaction | PHF19 interactions | 2.82e-04 | 66 | 39 | 3 | int:PHF19 | |
| Interaction | NR1H2 interactions | 3.08e-04 | 68 | 39 | 3 | int:NR1H2 | |
| Interaction | CFAP100 interactions | 3.27e-04 | 14 | 39 | 2 | int:CFAP100 | |
| Interaction | RANGAP1 interactions | 3.32e-04 | 314 | 39 | 5 | int:RANGAP1 | |
| Interaction | CAVIN3 interactions | 3.50e-04 | 71 | 39 | 3 | int:CAVIN3 | |
| Interaction | CEP63 interactions | 3.88e-04 | 179 | 39 | 4 | int:CEP63 | |
| Interaction | AKIRIN2 interactions | 3.95e-04 | 74 | 39 | 3 | int:AKIRIN2 | |
| Interaction | GUSBP5 interactions | 4.11e-04 | 75 | 39 | 3 | int:GUSBP5 | |
| Interaction | ZNF557 interactions | 5.47e-04 | 18 | 39 | 2 | int:ZNF557 | |
| Interaction | FBXO22 interactions | 5.54e-04 | 540 | 39 | 6 | int:FBXO22 | |
| Interaction | PGR interactions | 5.73e-04 | 84 | 39 | 3 | int:PGR | |
| Interaction | TRAF3IP3 interactions | 5.73e-04 | 84 | 39 | 3 | int:TRAF3IP3 | |
| Cytoband | 2p11.2 | 2.28e-05 | 64 | 39 | 3 | 2p11.2 | |
| Cytoband | 2q13 | 2.73e-05 | 68 | 39 | 3 | 2q13 | |
| Cytoband | 2q12.3 | 9.49e-05 | 17 | 39 | 2 | 2q12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | 7.96e-04 | 213 | 39 | 3 | chr2p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q13 | 1.17e-03 | 59 | 39 | 2 | chr2q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q12 | 2.24e-03 | 82 | 39 | 2 | chr2q12 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | RGPD1 RGPD4 TTC27 RGPD2 RANBP2 NCF2 RGPD8 DNAJC7 RGPD3 RGPD5 | 1.96e-15 | 115 | 30 | 10 | 769 |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.44e-03 | 34 | 30 | 2 | 487 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.48e-03 | 53 | 30 | 2 | 532 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 7.80e-12 | 33 | 39 | 6 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 4.25e-11 | 43 | 39 | 6 | MM3857 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RGPD1 RGPD4 RGPD2 RANBP2 RGPD8 P2RX4 SUGP2 DOCK9 RGPD3 RGPD5 | 1.35e-09 | 474 | 39 | 10 | M40991 |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 3.21e-06 | 435 | 39 | 7 | MM1221 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | 3.97e-05 | 1158 | 39 | 9 | MM1338 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | 8.46e-05 | 1277 | 39 | 9 | MM1032 | |
| Coexpression | GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN | 1.18e-04 | 170 | 39 | 4 | M2942 | |
| Coexpression | TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN | 1.19e-04 | 327 | 39 | 5 | M2351 | |
| Coexpression | TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN | 1.37e-04 | 337 | 39 | 5 | MM1069 | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-05 | 173 | 39 | 4 | b335ca2a247156eba821943b2b9fc9922230b409 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-05 | 182 | 39 | 4 | 4234d0cc57b5266a5e03133c75c7918abe48465e | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 2.21e-05 | 189 | 39 | 4 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.71e-05 | 199 | 39 | 4 | 41f046646fff65b7e51b63d3204f76ef32054781 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.71e-05 | 199 | 39 | 4 | ef7f7f7c861827574b120f48cf4052c563929081 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.76e-05 | 200 | 39 | 4 | 2488aa12970a43a5af352e2c36c73884d73a1cc5 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.76e-05 | 200 | 39 | 4 | e786544cf6f891550c4be55ebb4928c92297b504 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-05 | 101 | 39 | 3 | 6c4524be89cf3eb06769c2963dcded3da1e71ca0 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-04 | 142 | 39 | 3 | be63c48794a227ea55978524c0f5935342fc455e | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-Treg|ICU-SEP / Disease, Lineage and Cell Type | 2.75e-04 | 145 | 39 | 3 | ee99b58462f955b96d036aa67e343db047d66f64 | |
| ToppCell | severe_influenza-Treg|World / disease group, cell group and cell class (v2) | 2.98e-04 | 149 | 39 | 3 | 2a3a00cdf604c8f3f3863df0ddb06938549bf86d | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.22e-04 | 153 | 39 | 3 | 7480522a47e367f8facc4f5d599fbaf0b5ad4007 | |
| ToppCell | severe_influenza-Treg|severe_influenza / disease group, cell group and cell class (v2) | 3.28e-04 | 154 | 39 | 3 | 25f74dfb0f0e014a232bc5318928c478480b178d | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.35e-04 | 155 | 39 | 3 | 03fd443740272dcb547e39deaf7ae89b8307f241 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.41e-04 | 156 | 39 | 3 | 53ded973358e3e48054130131e959f0d1f4ef60f | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 3.41e-04 | 156 | 39 | 3 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.67e-04 | 160 | 39 | 3 | 18954241e11309ecb0f3ca87897eadcb20dc8eca | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.74e-04 | 161 | 39 | 3 | 5a8698790f9aba796dd2b64af419055c60bd7de8 | |
| ToppCell | tumor_Lung-Myeloid_cells-Pleural_Mac|tumor_Lung / Location, Cell class and cell subclass | 3.81e-04 | 162 | 39 | 3 | 9ac3242511315224ed94582aca9e9a3786cd01a0 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.09e-04 | 166 | 39 | 3 | bb8135119dc37fdbba476599a56d368f422688dc | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.16e-04 | 167 | 39 | 3 | 8fede587572d465cb63f7828141a574185bbb819 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.46e-04 | 171 | 39 | 3 | 41932c9e70829ee3d55ca5fdb74d290fc8229416 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.53e-04 | 172 | 39 | 3 | 3b9be685fcd1634498a603b692f5ac6ddd0de176 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.61e-04 | 173 | 39 | 3 | bba8265a58f8f5659dc7b9da2fe27b15033fce34 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 4.61e-04 | 173 | 39 | 3 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.69e-04 | 174 | 39 | 3 | cb0109661e8c9ca04d67d33f2d926f0e649bf67d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.69e-04 | 174 | 39 | 3 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.77e-04 | 175 | 39 | 3 | d3890bd0c570bb81434fdd1c5229891cefe2e462 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 4.85e-04 | 176 | 39 | 3 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-04 | 176 | 39 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.93e-04 | 177 | 39 | 3 | 227d4f423b00be2e0c5797e2c5275d342e69a0f4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.93e-04 | 177 | 39 | 3 | 66ffa279147961080c104242a08b176e301d80e3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.93e-04 | 177 | 39 | 3 | 0cbf54608d2ba0a0500af142f2029fe5e118c3c2 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 4.93e-04 | 177 | 39 | 3 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-04 | 178 | 39 | 3 | 24e8c62060455159235985f456af0c5023a7f3f5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-04 | 178 | 39 | 3 | 4f1cc954d4d9b5b2b75a4cf995ba81e2ada27084 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.09e-04 | 179 | 39 | 3 | 35fe9961e228ce255e3317fc244efa35b5adbf8b | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.09e-04 | 179 | 39 | 3 | ab3d08b51cd7a37582305615ee221c7a2af83b40 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.18e-04 | 180 | 39 | 3 | 8ab16a0b9053bffc07b569a4f9e71749f56dde7e | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.18e-04 | 180 | 39 | 3 | 394cd465b88429b70eebb2957480dffcbc51cfe7 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.26e-04 | 181 | 39 | 3 | 166ff44fcc0a2943b7f485ea8a9c314964e013bb | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 5.35e-04 | 182 | 39 | 3 | 9adf90bb2808f234d53b89ca0ae07380478204ad | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.43e-04 | 183 | 39 | 3 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 5.52e-04 | 184 | 39 | 3 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 5.61e-04 | 185 | 39 | 3 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.69e-04 | 186 | 39 | 3 | ddfadd43efeac3b3e6b7062590cc2b8f2f2db2ab | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.78e-04 | 187 | 39 | 3 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | metastatic_Brain-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 5.78e-04 | 187 | 39 | 3 | 7375f70a970a5d5a58b7c33ada2dcf6dcef525c6 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-04 | 187 | 39 | 3 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.97e-04 | 189 | 39 | 3 | 9e3c083174a64ea78648c6d48498fc4e721b569f | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.97e-04 | 189 | 39 | 3 | 6e19bfa52406ebe095daa99f958ec4d596ce6e39 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-04 | 190 | 39 | 3 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 6.06e-04 | 190 | 39 | 3 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.06e-04 | 190 | 39 | 3 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-04 | 190 | 39 | 3 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-04 | 190 | 39 | 3 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.15e-04 | 191 | 39 | 3 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.15e-04 | 191 | 39 | 3 | cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.15e-04 | 191 | 39 | 3 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.15e-04 | 191 | 39 | 3 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.17e-04 | 42 | 39 | 2 | b0ebd9d2456e4bab44e91b35d728224da6a052ea | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.24e-04 | 192 | 39 | 3 | 189477c44040cf0ee16c3932fa49fbd9e3acaa3c | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.24e-04 | 192 | 39 | 3 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.34e-04 | 193 | 39 | 3 | bd0027fa97de41ae22ff64a61c8e217496f122ca | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 6.34e-04 | 193 | 39 | 3 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.34e-04 | 193 | 39 | 3 | b9dcffd28ca309359fb110fb79de8ce066208ee1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.34e-04 | 193 | 39 | 3 | 7deb439943d35a4e825674b2b7dcddb45d366ad1 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Exhausted_CD8+_T|normal_Pleural_Fluid / Location, Cell class and cell subclass | 6.43e-04 | 194 | 39 | 3 | 68a9e00c9e1a855eeebfc26c038652f3800758db | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.43e-04 | 194 | 39 | 3 | 40c91ed945bd5990a0dbf2090d37a660b19aaab2 | |
| ToppCell | 343B-Myeloid-Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.53e-04 | 195 | 39 | 3 | 48ba2044d2459c8b0d17bc7deca8d0195ac6a00e | |
| ToppCell | tumor_Lung-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 6.53e-04 | 195 | 39 | 3 | 3133591a289c06396cf4705d6a861369e145ac54 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 6.63e-04 | 196 | 39 | 3 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-sinusoidal_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.73e-04 | 197 | 39 | 3 | f1080d93acf1a4756d2f2c8cabd1fb50bc7bcd09 | |
| ToppCell | 390C-Myeloid-Monocyte-CD16+_Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.73e-04 | 197 | 39 | 3 | 01f5f5c34e904cc0146e978cc05ed1cd86a41533 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.73e-04 | 197 | 39 | 3 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.73e-04 | 197 | 39 | 3 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | tumor_Lung-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 6.73e-04 | 197 | 39 | 3 | a05237ee6d31d9eab491dd7007859d6285cf1424 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.73e-04 | 197 | 39 | 3 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | medial-Hematologic-Interstitial_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.73e-04 | 197 | 39 | 3 | b90c8a41e99c87b46be699d03cd49c97a2ad51af | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 6.73e-04 | 197 | 39 | 3 | 2bf540fa228687a71f595a807e4a2af20588a82c | |
| ToppCell | medial-Hematologic-Interstitial_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.73e-04 | 197 | 39 | 3 | 13aec816e21754eac590a12c3a9c795c41108277 | |
| ToppCell | medial-2-Hematologic-Interstitial_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.73e-04 | 197 | 39 | 3 | 38a74eeb2a4c8d6a86b133f02f4e6c641f16a3ac | |
| ToppCell | 10x5'v1-week_12-13-Endothelial|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.83e-04 | 198 | 39 | 3 | 307dd09e6bc820a148f3000f18dae7aedba4be0b | |
| ToppCell | distal-2-Hematologic-Alveolar_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.83e-04 | 198 | 39 | 3 | a8093144cbe3069c25a6c1f1c94218a115da8748 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.83e-04 | 198 | 39 | 3 | 5d42f4fda2081ea3e9f62a00e7eea702e0d0be7d | |
| ToppCell | medial-Hematologic-Alveolar_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.83e-04 | 198 | 39 | 3 | d64f3d806594619607a72025a93b43ed4efaed01 | |
| ToppCell | distal-Hematologic-Alveolar_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.83e-04 | 198 | 39 | 3 | cd56124ff98a194ec030588dac684535a31cb5e4 | |
| ToppCell | medial-Hematologic-Alveolar_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.83e-04 | 198 | 39 | 3 | 8a21f885d26959b349eb4ca027328d6cf0f1b9cf | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.83e-04 | 198 | 39 | 3 | 9430ce7016b1a4724de036aab3e3e4082d24e436 | |
| ToppCell | distal-Hematologic-Alveolar_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.83e-04 | 198 | 39 | 3 | e1dc5a56fc23d3b1b4350d7162acec5762115b64 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-MoAM-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.83e-04 | 198 | 39 | 3 | 1d92b09aeb03a95fa9e221813002045c4f41dd24 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.83e-04 | 198 | 39 | 3 | 122215d9288533ad03562cf777e846504863df9a | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.83e-04 | 198 | 39 | 3 | 99d6a64f3410dae3019161feef20a8f06081a24b | |
| ToppCell | medial-2-Hematologic-Alveolar_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.83e-04 | 198 | 39 | 3 | ad8b9ac155737f794bf1974c59f8143c6ef63d71 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.83e-04 | 198 | 39 | 3 | 1771c282cd6422c35a4131c827d7daedfd6e7541 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.83e-04 | 198 | 39 | 3 | 6b81e74888f9bd004fcfe51f191c6ce7050cdc36 | |
| ToppCell | distal-2-Hematologic-Interstitial_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.93e-04 | 199 | 39 | 3 | d4caf296b6ce22a10b78d0efd4e018d867ccb78a | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.93e-04 | 199 | 39 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.93e-04 | 199 | 39 | 3 | e25a67a196f226b60b4aa0ff0cf4471d66333445 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-MoAM-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.93e-04 | 199 | 39 | 3 | 1ce46d9edabb3252f940a5143dd3f2404422d185 | |
| Drug | halofenate | 1.71e-05 | 4 | 39 | 2 | CID000033584 | |
| Drug | Pirenperone [ 75444-65-4]; Up 200; 10.2uM; HL60; HT_HG-U133A | 2.09e-05 | 197 | 39 | 5 | 2455_UP | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 1uM; PC3; HT_HG-U133A | 2.14e-05 | 198 | 39 | 5 | 3736_UP | |
| Drug | Molsidomine [25717-80-0]; Up 200; 16.6uM; PC3; HT_HG-U133A | 2.19e-05 | 199 | 39 | 5 | 6325_UP | |
| Disease | alcohol and nicotine codependence | 1.12e-04 | 13 | 36 | 2 | EFO_0004776 | |
| Disease | multiple myeloma (is_marker_for) | 8.88e-04 | 36 | 36 | 2 | DOID:9538 (is_marker_for) | |
| Disease | Moyamoya disease | 1.10e-03 | 40 | 36 | 2 | MONDO_0016820 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.64e-03 | 49 | 36 | 2 | DOID:0060037 (implicated_via_orthology) | |
| Disease | forced expiratory volume | 2.56e-03 | 789 | 36 | 5 | EFO_0004314 | |
| Disease | gut microbiome measurement, bone density | 4.10e-03 | 78 | 36 | 2 | EFO_0003923, EFO_0007874 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 5.96e-03 | 303 | 36 | 3 | EFO_0004612, EFO_0020945 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVFESEYSRKKYYYV | 941 | O95490 | |
| LKAYVLYKEYDLYGQ | 566 | A6NK59 | |
| EYKGYEEITFYEYLK | 311 | P24386 | |
| YFAKLYYEAKEYDLA | 31 | P49792 | |
| YYEAKEYDLAKKYIC | 36 | P49792 | |
| YYREKKYKYVEDYEQ | 366 | Q99571 | |
| YFAKLYYEAKEYDLA | 31 | Q99666 | |
| YYEAKEYDLAKKYIC | 36 | Q99666 | |
| YFAKLYYEAKEYDLA | 31 | O14715 | |
| YYEAKEYDLAKKYIC | 36 | O14715 | |
| FVDAFLKYEKADKYY | 26 | Q9Y5S8 | |
| LKYEKADKYYYTRKI | 31 | Q9Y5S8 | |
| CVLYYYLTKKNENYK | 466 | Q9Y618 | |
| YYQTEKYDLAIKDLK | 81 | P19878 | |
| KYQYAIDEYYRMKKE | 131 | Q8N128 | |
| EEGLYYNKAIDYYLK | 931 | Q3B7T1 | |
| EYCLKYMKYEKSYRF | 211 | Q9H7Z6 | |
| DFKDYTLLYEEAKYF | 101 | Q719H9 | |
| YFAKLYYEAKEYDLA | 31 | A6NKT7 | |
| YYEAKEYDLAKKYIC | 36 | A6NKT7 | |
| AELYEYKKKYSDADI | 1851 | Q14008 | |
| KYAYKAEPYVASEYK | 916 | Q9BZ29 | |
| YNLYYAYLPAKLDKK | 661 | Q5T3F8 | |
| EFYVYFLKDEDYLKD | 571 | Q68CZ6 | |
| QYKEKEDRYVDTYKY | 3196 | Q99698 | |
| KKDYNEAYNYYTKAI | 41 | Q99615 | |
| FYFAKLYYEAKEYDL | 21 | P0DJD0 | |
| LYYEAKEYDLAKKYV | 26 | P0DJD0 | |
| IYKDYQYYFSKEKET | 806 | P22897 | |
| YFAKLYYEAKEYDLA | 31 | Q7Z3J3 | |
| YYEAKEYDLAKKYIC | 36 | Q7Z3J3 | |
| LKYKYKDYHTLKVYE | 1401 | A0AVI2 | |
| FAKLYYEAKEYDLAK | 31 | P0DJD1 | |
| LYYYLTKKNENYKAL | 476 | O75376 | |
| YYSYKAVKSKDIKEY | 21 | Q9H902 | |
| EYLCDYKKIREQEYY | 46 | O43463 | |
| EDVYLYYKLAYEHKF | 2406 | Q96JI7 | |
| KKHLDKYIPYKYVIY | 441 | Q63HN8 | |
| QVPYKYDLYEKTLKY | 101 | Q6P2D0 | |
| EEYYYAKDYTKALKL | 461 | Q7Z392 | |
| YLCDYKVVKDMEYYL | 51 | Q9H5I1 | |
| DENSLEYKYYKLKLA | 621 | Q8IX01 | |
| KYYYDGKDYIEFNKE | 136 | P25311 | |
| FLYYYEYRKAKDQLD | 241 | Q6P3X3 | |
| KKYLDVKFEYLSYCL | 251 | Q9NRD5 | |
| RDIASDYKYKYNYEK | 2056 | P20929 | |
| SYFKYKEAYEHTKAY | 4981 | P20929 |